Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Nashville TN, Birmingham AL, Atlanta GA, Charlotte NC,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase 1, Phase 2, Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Nashville TN, Charlotte NC, Detroit MI, Shreveport LA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase 2, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Nashville TN, Birmingham AL, St Louis MO,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase 1, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Nashville TN, St Louis MO, Indianapolis IN, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase 1, Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Atlanta GA, Orlando FL, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Nashville TN, Fairfax VA, Dallas TX, Orlando FL,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Nashville TN, New Orleans LA, Orlando FL, Denver CO
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase 1, Phase 2, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Nashville TN, Atlanta GA, St Louis MO, Durham NC,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

for
Solid Tumor, Adult, Solid Tumor, Melanoma, Basal Cell Cancer,
Location: Denver CO, Nashville TN
Sponsor: Rise Therapeutics LLC

Sex: All

Age: 18 - 70+

Code: NCT06398418

Phase 1, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Denver CO, Nashville TN, Atlanta GA, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase 1, Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic,
Location: Nashville TN, Richmond VA, Saint Augustine FL,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05254743

Phase 3, Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for
Triple Negative Breast Cancer
Location: Nashville TN, Chicago IL, New York NY, Aurora CO,
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06908928

Phase 1, Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for
Epidermal Growth Factor, Epidermal Growth Factor Receptor,
Location: Nashville TN, Houston TX, East Brunswick NJ,
Sponsor: EpiBiologics

Sex: All

Age: 18+

Code: NCT07462377

Phase 1, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Nashville TN, Birmingham AL, Augusta GA, Chicago IL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

for
Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative
Location: Chattanooga TN, Cincinnati OH, Columbus OH, Chicago IL,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04468061

Phase 2, Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Nashville TN, St Louis MO, Cleveland OH, Madison WI,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase 1, Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: Nashville TN, St Louis MO, Fairfax VA, Sarasota FL,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase 1, Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: The Woodlands TX, Germantown TN, Newnan GA, Edgewood KY,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06588478

Phase 2, Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

for
Cancer, Melanoma Stage III, Melanoma Stage IV,
Location: Nashville TN, Indianapolis IN, Canton OH, Cleveland OH,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05970497

Phase 1, Phase 2, Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for
Neutropenia
Location: Woodland TX, Memphis TN, Atlanta GA, Cincinnati OH,
Sponsor: X4 Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06056297

Phase 3, Recruiting